Genome insertions and deletions (indels) show tremendous functional impacts despite they are much less common than single nucleotide variants, which are at the center of studies assessing cancer mutational signatures. We studied 8891 tumor samples of 32 types from The Cancer Genome Atlas in order to explore those genes which are potentially implicated in cancer indels. Survival analysis identified in-frame indels as the most important variants predicting adverse outcome. Transcriptome-wide association study identified 16 genes overexpressed in both tumor samples and tumor types with high number of in-frame indels, of whom four (APOBEC1, BCL2L15, FOXL1 and PDX1) were identified with gene products distributed within the nucleus. APOBEC1 emerged as the mere consistently hypomethylated gene in tumor samples with high number of in-frame indels. The correlation of APOBEC1 expression levels with cancer indels was independent of age and defects in DNA homologous recombination (HR) and/or mismatch repair. Unlike frame-shift indels, triplet repeat motifs were found to occur frequently at in-frame indel sites. The splicing variant 3, making a shorter isoform b, showed essentially all the same indel correlations as of APOBEC1. Expression levels of both APOBEC1 and variant 3 were found to be predicting adverse prognosis independent of DNA HR and mismatch repair. Not less importantly, high level of variant 3 in paired normal tissues was also proved to predict cancer outcome. Our findings propose APOBEC1 and isoform b as the potential endogenous mutators implicated in cancer in-frame indels and pave the way for their use as novel prognostic tumor markers.
Introduction
Somatic mutations are hallmarks of cancer genomes. Insertion or deletion (indel) of nucleotides with potentially important functional implications constitutes the second most common class after single-nucleotide variants (SNVs) in cancer. Recent works indicate that indel variants are associated with six mutational signatures (1) . While the signature 1 is age-dependent, the signature 3 is associated with defects in the double-strand break repair by homologous recombination (HR) due to BRCA1/ BRCA2 inactivation. The remaining signatures including 6, 15, 20 and 26 are supposed to be related to defects in DNA mismatch repair (MMR) causing microsatellite instability. DNA microsatellites are defined as genomic repeats of 2-5 nucleotide size (2) which are hot spots for indel variants when the postreplicative DNA repair is defective (3) . Microsatellite instability is commonly seen in endometrial (4), gastric (5), pancreatic (6) and colorectal cancers (7) . Although the role of defective DNA repair pathways has been much studied in cancer indels (3) (4) (5) (6) (7) , few works have attempted to unravel those molecular mechanisms underlying the original DNA insult. This is in sharp contrast to particular SNVs which have already been attributed to APOBEC family members, including APOBEC3B (8, 9) , APOBEC3A (9,10) and APOBEC3H (11) with endogenous mutator activities.
In this study, we have attempted to explore those genes which are potentially implicated in cancer indels, particularly in a pancancer setting. We hypothesized that gene expression changes underlie cancer indels regardless of the potential DNA repair pathways implicated. Survival analysis identified in-frame indels as the most important genomic variants predicting cancer outcome. We next proceeded to discover candidate genes implicated in cancer in-frame indels by identifying differentially expressed genes among both tumor samples and tumor types, and validated the results using gene methylation findings. The final candidate gene, namely APOBEC1, and a particular variant were found to be independently predicting both in-frame indels and adverse outcome.
Materials and methods

Patients and samples
The results shown here are based upon data generated by TCGA Research Network: http://cancergenome.nih.gov/. The complete lists of somatic mutations identified by whole-exome sequencing of 8891 paired tumornormal samples were obtained from TCGA Data Portal as .maf files (Level 2, v.20151009), comprising 32 tumor types from 26 primary sites (Supplementary Table 1 , available at Carcinogenesis Online). These data had been collected from a total of 105 sequencing runs performed by seven participating Centers. A total of 2 458 352 duplicate mutations identified by multiple sequencing runs were removed, leaving 2 338 886 unique variants. The following open access (Level 3) databases were obtained from Broad Institute GDAC Firehose (http://gdac.broadinstitute.org/): normalized RNASeq by Expectation-Maximization (RSEM) for genes (RSEM_genes_normal-ized_data, v.20160128) and isoforms (RSEM_isoforms_normalized_data, v.20160128), gene methylation (meth.by_min_expr_corr.data, v.20160128) data and clinical data including age, sex, vital status and days to death/ last follow-up (Clinical_Pick_Tier1, v.20160128). The normalized RSEM data resulted from RNA-sequencing was used as an estimate of TCGA gene expression profiles, and they were further normalized to TBP (TATA-binding protein) expression levels. Indels of longer than one nucleotide were classified based on their 5ʹ-end nucleotide. The list of HR and MMR genes were obtained from Kyoto Encyclopedia of Genes and Genomes (KEGG maps ko03440 and ko03430, respectively), and all exome variants except for silent ones were included for analysis of implicated DNA repair pathways. The list of oncogenes and tumor suppressor genes were obtained from a census of human cancer genes (12) and Cosmic supplemental analysis information (http://cancer.sanger.ac.uk/census#cl_analysis).
Statistical analysis
Pearson correlation analysis (IBM SPSS, v.22) was used in order to assess the correlation of various indels to each other and to study the correlation of the number of in-frame indel variants in each tumor exome with TBP-normalized expression levels of 30 762 genes/gene variants, as well as APOBEC1 variants. Pearson correlation analysis was also conducted to examine the correlation of the mean number of in-frame indels in each tumor type with the mean normalized expression levels of 30 762 genes/ gene variants, as well as APOBEC1 variants. Pearson correlation analysis was performed in order to assess the correlation of the number of in-frame indel variants in each tumor exome with methylation levels of candidate genes. Benjamini-Hochberg false discovery rate (FDR) was used to adjust for multiple testing in Pearson correlation analyses, with acceptable FDR of up to 0.05. Multivariate linear regression analysis (IBM SPSS, v.22) was performed in order to assess the impact of multiple covariates on the number of in-frame indels, including high-APOBEC1 status, HR-mutant status, MMR-mutant status and age. The significance and extent of enrichment of the in-frame indels in oncogenes as compared to tumor suppressor genes were tested using two-sided Mantel-Haenszel test (IBM SPSS, v.22). Two-sided Mantel-Haenszel test was also used to test the significance and extent of enrichment of the homologous triplet units among inframe indels and their contexts. Unpaired two-tailed Student's t-test (IBM SPSS, v.22) was used to compare the mean number of indels among low-APOBEC1 versus high-APOBEC1, HR-intact versus HR-mutant and MMRintact versus MMR-mutant samples, tumor types with/without indel signatures, as well as in-frame indel counts among various groups. Paired two-tailed Student's t-test (IBM SPSS, v.22) was used to compare the mean APOBEC1 expression levels among tumor and normal samples. Gene-E was used in order to show the correlation heat map of various indels, and Graphpad Prism (v.5.0.1) to illustrate the correlations of gene expression levels and indel numbers. The R (v.3.1.1) package 'seqinr' (v.3.1.3) (13) was used to identify the genomic context for each indel site, including genomic positions −30 to +30. The R package 'ClusteredMutations' (v.1.0.1) was used to plot exome inter-mutation distance against genomic position. Indel kataegis events were defined by clusters of at least two indels of the same type occurring within 1000 base distance. WebLogo (v.3.4) (14) was used to show the nucleotide probability logos within indel context, as well as for illustrating the triplet repeat motifs. Motif-x (v.1.2) (15) was used to discover significantly enriched context motifs and their enrichment between positions −12 and +12. The genomic context of the corresponding frame-shift indels using all studied exomes were considered as the background, with a minimum acceptable significance of 10 −10 .
Prognostic analysis
Overall survival (OS) was measured from the date of patient enrolment to the date of death or last known alive. Cox regression analysis (IBM SPSS, v.22) was used for univariate analysis of the survival using the number of six mutational classes, including SNVs, double-nucleotide variants, frame-shift deletions, frame-shift insertions, in-frame deletions and in-frame insertions in all cancer cases as the covariates. Cox regression analysis was also used for univariate analysis of the survival using high-APOBEC1 or high-Var3 in all cancer patients as the covariate, with age, sex and HR and MMR-mutant status considered in multivariate analysis. Kaplan-Meier analysis was performed using Figure 2B , available at Carcinogenesis Online). Closely-clustered mutations (kataegis) are assumed to be caused by the same molecular mechanism (16) , and analysis of kataegis plots revealed much smaller insertion clusters compared to deletion ones. In other words, mean distances between clustered DelA/T and DelC/G events were found to be 111 and 149 nucleotides, respectively (Supplementary Figure 2C , available at Carcinogenesis Online), while they were 7 and 25 nucleotides in the case of clustered InsA/T and InsC/G events, respectively (Supplementary Figure 2D , available at Carcinogenesis Online). These suggested shared underlying mechanisms implicated in deletions and insertions. Survival analysis identified IFD and IFI classes as the most deleterious variants, followed by frame-shift deletion class ( Figure 1 ). Overall, 32 838 in-frame indels (1.4% of all variants) predicted adverse overall survival (OS) much more significantly [hazard ratio = 1.011, 95% confidence interval (CI): 1.008-1.013, P = 2 × 10
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] than frame-shift ones (hazard ratio = 1.001, 95% CI: 1.000-1.001, P = 0.026) and other variant classes, proposing them as the most important class in cancer driver mutations. Assessment of the indel-affected genes for functional roles identified the ratio of in-frame indels to be about 2.3 times higher in oncogenes compared to tumor suppressor genes (Supplementary Figure 3 , available at Carcinogenesis Online).
APOBEC1 expression level as the optimal predictor of indel variants
The expression profiles of 30 762 genes and gene variants were screened for correlation with the number of exome in-frame indels, showing 1237 differentially expressed genes (844 overexpressed and 393 underexpressed) in those tumor samples with frequent in-frame indels (Supplementary Table 2 , available at Carcinogenesis Online). Likewise, 39 genes were found to be differentially expressed (all overexpressed) in those tumors with high mean number of in-frame indels (Supplementary Table 3 , available at Carcinogenesis Online). Overall, 16 genes were identified to be overexpressed among both tumor samples and tumor types with frequent in-frame indels (Table 1) . Gene ontology assessment identified four overexpressed genes including APOBEC1, BCL2L15 (BCL2 like 15), FOXL1 (forkhead box L1) and PDX1 (pancreatic and duodenal homeobox 1) whose products were localized to the nucleus, suggestive of candidate genes implicated in in-frame indels. The gene products of the latter two are known as transcriptional regulators (17, 18) , and a pro-apoptotic function has been shown for BCL2L15 (19) ; none of them has been reported to be mutagenic. APOBEC1, however, is known as both mRNA and DNA modifier. Moreover, APOBEC1 was seen as the only gene which was consistently demethylated in those tumor samples with high number of in-frame indels (Supplementary Figure 4 , available at Carcinogenesis Online). The work-flow for transcriptome-wide association study has been depicted in Supplementary Figure 5 , available at Carcinogenesis Online.
We examined 712 available cases with paired normal-tumor samples across 21 cancer types and did not observe a significant difference in expression levels of APOBEC1 (Student's t-test P = 0.09). However, after exclusion of the gastrointestinal samples (Supplementary Tables 2 and 3 , available at Carcinogenesis Online). Moreover, A1CF (APOBEC1 complementation factor 1) which is crucial in APOBEC1 mRNA editing activity, was not found to be differentially expressed in high in-frame indel states (Supplementary Tables 2 and 3 , available at Carcinogenesis Online). Reassessing the limited number of available experiments (21) revealed at least one clonal DelA/T variant within the BCR-ABL1 fusion gene upon overexpression of the rat APOBEC1 in K562 cells.
Because indel variants are frequent in six mutational signatures associated with age and HR/MMR defects, we tested the possibility that high-APOBEC1 confounded the impact of defective HR/MMR pathways. Mutations of the KEGG (Kyoto Encyclopedia of Genes and Genomes) HR/MMR pathway genes were used as an indicator of HR/MMR deficiency (Supplementary In-frame indels including IFDs (P = 2 × 10 -18 ) and IFIs (P = 0.044), as well as FSDs (P = 0.001) were seen to be significantly predicting the OS. Bars indicate the 95% confidence intervals. DNV, dinucleotide variant; FSD, frame-shift deletion; FSI, frame-shift insertion; IFD, in-frame deletion; IFI, in-frame insertion; SNV, single-nucleotide variant. Tables 4 and 5 , available at Carcinogenesis Online). Preliminary assessment showed that both HR-mutant (β coefficient = 0.26, P = 9 × 10 -138 ) and MMR-mutant (β coefficient = 0.32, P = 4 × 10 -214 ) indices highly predicted cancer indels, well reflecting the functional status of HR/MMR pathways. While in-frame indels were found to be mostly associated with high-APOBEC1 (high-A1) status (Figure 2A ), frame-shift indels were seen to be mostly associated with MMR mutational status ( Figure 2B) . A multivariate model identified high-APOBEC1 as the most important factor predicting in-frame indels ( Figure 2C ), while MMR and HR level and mutational status of HR/MMR genes. All factors are significantly associated with the number of in-frame and frame-shift indels. Multivariate regression analysis shows that in-frame indels are mostly dependent on high-APOBEC1 followed by MMR-mutant status (C), while frame-shift indels are mostly dependent on MMRmutant followed by HR-mutant status (D). Age does not appear to have any independent impact on cancer indels. Bars indicate the 95% confidence intervals. Unpaired two-tailed Student's t-test ***P < 10 −10 . β, Pearson correlation coefficient. 
Tumor exomes
Tumor types Sixteen genes were found to be common among both differentially expressed genes in tumor exomes (1237) and differentially expressed genes in tumor types (22) with high number of in-frame (IF) indels (FDR or adjusted Pearson correlation analysis P ≤ 0.05).
a Pearson correlation β coefficient.
b Genes whose products are distributed within nucleus.
mutational status were found to be more important in frameshift indels ( Figure 2D ).
Triplet repeat motifs correlated with indel variants
We next analyzed the genomic contexts of 192 075 indel variants and identified that the nucleotide A was significantly enriched at essentially all positions in IndelA/T variants, while C was enriched at nearly all positions in IndelC/G variants ( Figure 3A-D) . Analysis of the 33 013 in-frame indel variants, however, showed a distinct pattern. The nucleotide A was found to be highly enriched at triple intervals in IndelA/T, particularly downstream to the indel site ( Figure 3E and G), and C was enriched at triple intervals in IndelC/G ( Figure 3F and H) . In fact, the genomic context for in-frame indels revealed certain triplet repeat motifs. The consensus motifs were seen to be (ASN) 4 A(GGA) 4 variants, respectively, was observed to be enriched 230 and 853 times. Analysis of the in-frame indel sequences showed them homologous to their contexts, with the first triplet of in-frame indels homologous to the first triplet of the context in 35.1% of events, showing about 27-fold enrichment (microhomologous; two-sided Mantel-Haenszel test P < 10 -300
).
APOBEC1 transcript variant 3 showing the same APOBEC1 correlations
We next explored the potential correlation of in-frame indels with particular APOBEC1 splicing variants, including NM_001644, NM_001304566 and NM_005889. The former two, transcript variants 1 and 2 respectively, give rise to the full-length isoform a (NP_001635 and NP_001291495), while the latter variant 3 (Var3) with an alternative start codon within exon 2 yields the shorter isoform b (NP_005880). 
Prognostic implication of expression levels of APOBEC1 and Var3
Pancancer survival analysis revealed both high-APOBEC1 (hazard ratio = 1. Table 6A , available at Carcinogenesis Online) identified age, male gender, high-APOBEC1 and HR mutations to be independently predicting pancancer outcome, with no remaining impact of MMR mutations (Supplementary Table 6B , available at Carcinogenesis Online). High-Var3 was also found to have a similar independent prognostic impact (Supplementary Table 6C , available at Carcinogenesis Online). Finally, the fact that high levels of the APOBEC1/Var3 in tumor cells were found to be an independent prognostic factor raised a question that whether they were also predictive of poor outcome in paired normal tissues. Examining 712 cases with available normal samples did not show significant prognostic value for high-APOBEC1 levels in paired normal tissues, neither in pancancer analysis (21 tumor types available) nor among nongastrointestinal cancer cases. However, a similar analysis using high-Var3 levels demonstrated high prognostic impact in paired normal tissues of cancer patients in pancancer analysis (hazard ratio = 1.60, 95% CI = 1.08-2.35), and the impact was even higher when analysis was limited to non-gastrointestinal cancers (hazard ratio = 2.49, 95% CI = 1.16-5.30). Median survival time was found to be 876 days shorter in those cases with normal tissue high-Var3 in pancancer analysis, and 921 days shorter in non-gastrointestinal cancers with high-Var3 (Supplementary Figure 14 , available at Carcinogenesis Online).
Discussion
We performed a transcriptome-wide association study in 8891 tumor samples of 32 types in order to screen those genes whose expression levels were associated with in-frame indels as the single most important mutational variant predicting poor cancer outcome. This identified 16 genes whose expression levels were correlated with the number of in-frame indels both in tumor samples and tumor types. We further narrowed down to four candidate genes including APOBEC1, BCL2L15, FOXL1 and PDX1 by exclusion of those genes whose products lacked a nuclear distribution. Methylation analysis of the latter candidate genes across 8891 tumor samples identified APOBEC1 as the only gene with methylation status inversely correlated with in-frame indels. A pro-apoptotic role has been shown for BCL2L15 (19) , and both FOXL1 and PDX1 have been known as transcriptional regulators (17, 18) ; none of them reported to be mutagenic. APOBEC1 was next confirmed to be overexpressed in primary non-gastrointestinal tumors. On the other hand, the magnitude of APOBEC1 indel impact appeared to be comparable to A3B impact on C>G/T variants (8) . The absence of other APOBEC/AID family members among differentially expressed genes excluded the possibility that APOBEC1 just co-expressed with another truly implicated family member, including APOBEC3B or APOBEC3A.
Two mutational signatures have been attributed to APOBEC/ AID family (1), particularly APOBEC3B (8, 9) , APOBEC3A (9,10) and APOBEC3H (11) . However, the implication of other family members with nuclear distribution, including APOBEC1 (23), APOBEC3C (24) and APOBEC3F (25) in cancer mutations remains to be investigated. Activation-induced deaminase (AID), which is normally involved in antibody diversification through DNA editing, has long been known for its tumorigenic impact in B-cell leukemia and lymphoma through off-target genomic deamination and induction of chromosomal translocations (26) . While APOBEC1 had been recognized to deaminate cytidine in certain mRNAs (27) , it was later found to be a DNA mutator as well (28, 29) . Sustained APOBEC1 overexpression in mouse liver was shown to induce hepatocellular carcinoma (30) , and examining three mRNA editing sites across 28 tumor types essentially excluded the possibility of mRNA editing at known target sites as the cause of APOBEC1 carcinogenesis (31, 32) . Besides some clonal indels we observed, APOBEC1 overexpression causes a mutational signature compatible to what is seen in esophageal adenocarcinoma (21) . On the other hand, APOBEC1 −/− dramatically decreases the formation of intestinal adenomas in APC min/+ mice. These propose an important role for APOBEC1 mutagenesis in gastrointestinal cancers (33) . The functions of AID and APOBEC1 are comparable in many aspects. AID causes DNA cytidine deamination leading to somatic hypermutations, which are associated with indels in up to 6% of mutational events (34, 35) , and the resultant in-frame indels increase the immunoglobulin diversity and potency (36, 37) . Both AID and APOBEC1 deaminate the methyl/hydroxymethyl cytidine (5mC/5hmC) in singlestranded DNA (38) , and APOBEC1 is the most potent family member deaminating 5hmC in brain cell DNA (39) . Furthermore, both AICDA and APOBEC1 are located in a cluster of pluripotency genes including NANOG and DPPA3 (developmental pluripotency associated 3), co-expressing in oocytes and embryonic germ/ stem cells (38) . A demethylating role has also been suggested for APOBEC1 in testicular carcinoma (22) , and APOBEC1 deficiency reduces the risk of mouse testicular germ cell tumors (20) .
We showed that the correlation of in-frame indels with high-APOBEC1 was independent of HR/MMR mutational status, as the proposed factors implicated in the indel mutational signatures. This is compatible with a role in causation rather than repair of in-frame indels. High-APOBEC1 impact was also reflected in its pancancer prognostic capacity independent of HR/MMR mutational status. We also identified triplet repeat motifs flanking in-frame indel sites, which might serve as DNA binding sites for implicated protein(s), as occurs in zinc-finger proteins including APOBEC family (40) . Intriguingly, one consensus triplet motif [(GGA) 4 ] has been reported to form G-quadruplex (G4) in the MYB promoter (41), with partial deletion giving rise to MYB transcriptional activation and complete deletion leading to MYB repression. The G4 motifs have been shown to form DNA binding sites for zinc-finger proteins (42) . High-APOBEC1 expression levels were found to be correlated with adverse prognosis in five tumors, including adrenocortical carcinoma, uterine endometrial carcinoma, pancreatic adenocarcinoma, mesothelioma and thyroid carcinoma. The fact that high-APOBEC1 showed a significant albeit less prognostic impact after exclusion of these tumors indicated that its impact was global and not just limited to latter five tumors.
We also explored APOBEC1 splicing variants in a search for more precise molecular explanations, identifying Var3 to be dominantly expressed in nearly all tumors studied, with the same indel and clinical associations as of APOBEC1. Var3 constitutes about half of the adult small intestine APOBEC1 mRNA as compared to nearly 90% in fetal small intestine (43) , indicating a more important role in stem/progenitor cells. Intriguingly, it is reported that alternative initiation events might occur in response to DNA damage (44) . The resultant isoform b lacks N-terminal 45 amino acids which are involved in nuclear localization of A1CF (27) and known to be essential for mRNA editing (45) . This, in addition to lack of APOBEC1-A1CF coexpression in high-IF indel states, might impair mRNA editing activity, probably contributing to adverse prognosis in these states. Increased Var3 expression seems to be an early high-impact event in mutagenesis/carcinogenesis, because it was found to be predictive of poor outcome even in paired normal tissues of cancer patients. The fact that APOBEC1 (46) and other family members including APOBEC3A (47), APOBEC3F (48, 49) and APOBEC3G (48, 50) exist as dimers/multimers might explain how the shorter isoform interferes with the mRNA editing functions of the fulllength one (51) . The promutagenic impact of APOBEC1 in a pluripotency context (38) may explain its carcinogenic role. Moreover, alterations in the length of repetitive DNA are known to create diversity (52) and APOBEC1 can be predicted to enhance genomic variation by introducing in-frame indels in normal pluripotent cells, as occurs in the immunoglobulin locus by AID (37) .
In-frame indels are more likely to cause gain-of-function rather than frame-shift ones, and it was therefore not surprising that they occurred more frequently in oncogenes than in tumor suppressor genes. Furthermore, tumors with frame-shift indels unaffected by nonsense-mediated decay are likely to make neoantigens (53), potentially recruiting tumor-infiltrating lymphocytes, which effectively kill tumor cells (54) . This might explain why frame-shift indels show less adverse clinical impact compared to in-frame ones. The programmed death-1 (PD-1) pathway which suppresses many immune cells including tumor-infiltrating lymphocytes (55) is upregulated in many tumors and their microenvironments, and its blockade has been successfully attempted in the treatment of several types of tumors, including melanoma, bladder cancer and small-cell lung cancer (56) . A recent study shows that MMR deficiency predicts those metastatic colorectal cancer cases who would benefit from PD-1 blockade (57). However, MMR deficiency was not seen to predict successful PD-1 blockade in non-colorectal tumors, and it would be intriguing to test whether high-APOBEC1 can be helpful in this regard.
In summary, pancancer prognostic analysis identified inframe indels as the most important cancer variants affecting patients' survival. Transcriptome-wide expression and methylation studies identified APOBEC1 as the only candidate gene with the expression and methylation levels correlated with the number of in-frame indels, and the splicing variant 3 mainly contributing to APOBEC1 impact. This indel impact was found to be independent of those DNA repair mechanisms which were proposed to be implicated in cancer indels. Unlike frame-shift indels, consensus triplet repeats were found to occur at in-frame indel sites. Expression levels of both APOBEC1 and variant 3 were found to predict pancancer outcome. However, surprisingly high prognostic value of high-APOBEC1/Var3 in cancers like pancreatic and thyroid carcinoma as well as mesothelioma promise the development of a novel predictive marker in these particular cancers. Moreover, high expression level of variant 3 was found to predict cancer outcome in paired normal tissues, suggesting it as an early mutagenic/carcinogenic event, and paving the way for its utilization as a novel prognostic marker in normal tissues. Our findings propose APOBEC1 and its isoform b as the endogenous mutators implicated in cancer in-frame indels, warranting extensive studies in order to validate both mutagenic and prognostic impacts of the high-APOBEC1 in various cancers.
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